Macleods Pharma USA is pulling two lots of a three-in-one blood pressure pill. The tablets failed a lab quality test.
Look for lot 12251163A on 30-count bottles and lot 12251163B on 90-count bottles. Both expire May 31, 2027.
The 30-count bottles carry NDC 33342-246-07. The 90-count bottles carry NDC 33342-246-10.
Each tablet holds 40 mg of olmesartan, 10 mg of amlodipine, and 12.5 mg of hydrochlorothiazide.
The pill is the generic version of the brand-name drug Tribenzor. Brand-name Tribenzor is not in this recall.
The tablets failed dissolution testing. They did not break down and release their drugs fast enough.
The olmesartan part dissolved at 79 percent in testing. The rule requires not less than 80 percent.
This is a quality problem, not a poisoning problem. The medicine may simply not control blood pressure as well.
The FDA classed the recall as Class II on October 26, 2026. Serious harm is considered unlikely.
Macleods started the voluntary recall on October 7, 2026. The recall is still ongoing.
A sudden stop can be riskier than the recall problem. Keep taking it and call your pharmacist or doctor.
Tap for lot numbers, NDC codes, and how this recall differs from October's Viatris recall.
Get the full breakdown, key numbers, and what happens next.
Read on Rive News